Coherus Oncology, Inc. (CHRS)

NASDAQ: CHRS · Real-Time Price · USD

1.020

+0.021 (2.10%)

Aug 14, 2025, 1:52 PM - Market open

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	2016 - 2018
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	2016 - 2018
Human Pharmaceutical Products	257.24M	Log In	Log In	Log In	Log In	Upgrade
Human Pharmaceutical Products Growth	21.89%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	2016 - 2018
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	2016 - 2018
United States	257.24M	Log In	Log In	Log In	Log In	Upgrade
United States Growth	21.89%	Log In	Log In	Log In	Log In	Upgrade